Together with Muscular Dystrophy Canada (MDC) we are pleased to invite you to a webinar on therapies for Duchenne muscular dystrophy. This webinar is primarily targeted at Canadian clinicians, academics, and trainees with an interest in neuromuscular disease. This is an independent clinical/academic webinar with no industry sponsorship or influence, and NMD4C and MDC are providing organizational and technical support.
Learning Objectives
- Understanding the muscle stem cell deficit in DMD.
- Development of small drugs that enhance muscle regeneration by mobilizing muscle stem cells.
- To review the benefits and challenges of classic glucocorticoid therapy (prednisone, deflazacort) for the treatment of DMD
- To discuss VBP15 (vamorolone), a novel “dissociative steroid” developed with the goal to separate the anti-inflammatory benefits of steroid therapy from the well-known adverse effects
- To summarize the results of clinical trials in ambulatory boys with DMD that highlight the impact of vamorolone on muscle, bone and endocrine outcomes
The NMD Rounds & Educational Webinars is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Date: Feb 06 2024
Time: 17:00 ET